In fact, many factors such as CCL-2, CCL-3, and CCL-5, whose gene expression was highly increased in preconditioned MSCs, were reported to be upregulated in patients with structural remodeling including hypertrophy and congestive heart disease [31]. This evidence concerns the gene CCL2 and cardiac hypertrophy.